Journal
JOURNAL OF PHYSIOLOGY AND BIOCHEMISTRY
Volume 73, Issue 2, Pages 199-205Publisher
SPRINGER
DOI: 10.1007/s13105-016-0539-8
Keywords
Hypertension; Na+/H+ antiport; NHEDC2; SLC; Sodium diet; Nephron
Categories
Funding
- National Institutes of Health [R01 DK108304, DK081610]
- Canadian Institute of Health Research
- University of Michigan-Dearborn startup funds
Ask authors/readers for more resources
Increased renal reabsorption of sodium is a significant risk factor in hypertension. An established clinical marker for essential hypertension is elevated sodium lithium countertransport (SLC) activity. NHA2 is a newly identified Na+(Li+)/H+ antiporter with potential genetic links to hypertension, which has been shown to mediate SLC activity and H+-coupled Na+(Li+) efflux in kidney-derived MDCK cells. To evaluate a putative role in sodium homeostasis, we determined the effect of dietary salt on NHA2. In murine kidney sections, NHA2 localized apically to distal convoluted (both DCT1 and 2) and connecting tubules, partially overlapping in distribution with V-ATPase, AQP2, and NCC1 transporters. Mice fed a diet high in sodium chloride showed elevated transcripts and expression of NHA2 protein. We propose a model in which NHA2 plays a dual role in salt reabsorption or secretion, depending on the coupling ion (sodium or protons). The identified novel regulation of Na+/H+ antiporter in the kidney suggests new roles in salt homeostasis and disease.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available